Contact Us Careers Register

Pharmaceutical Published Insights

Coherent Market Insights Tacrolimus Market

Published Date : 16 Feb, 2026

Tacrolimus is a calcineurin inhibitor and potent immunosuppressive drug that is primarily used to prevent cellular rejection following organ transplantation. It is also used topically to treat severe atopic dermatitis, severe refractory uveitis following bone mar... View more

Coherent Market Insights Budesonide Inhaler Market

Published Date : 16 Feb, 2026

Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhal... View more

Coherent Market Insights Clindamycin Phosphate Market

Published Date : 16 Feb, 2026

According to Coherent Market Insights, the global clindamycin phosphate market is estimated to be valued at USD 924.1 Mn in 2026 and is expected to reach USD 1,380.3 Mn by 2033, exhibiting a compound annual growth rate (CAGR) ... View more

Coherent Market Insights Graves’ Disease Market

Published Date : 16 Feb, 2026

According to Coherent Market Insights, the global graves’ disease market is estimated to be valued at USD 2.30 Bn in 2026 and is expected to reach USD 3.26 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of... View more

Coherent Market Insights Vaccine Contract Manufacturing Market

Published Date : 13 Feb, 2026

Vaccine Contract Manufacturing Market Size and Forecast – 2026 – 2033 The global vaccine contract manufacturing market is valued at around USD 3.0 billion in 2026 and is forecast to reach approximately USD 6.3 billion by 2033, representing a compound annual growth rate (CAGR) of about 8.45 % fr... View more

Coherent Market Insights Pemetrexed Market

Published Date : 13 Feb, 2026

Pemetrexed is a chemotherapy drug indicated for the treatment of pleural mesothelioma and non-small cell lung cancer. Pemetrexed is a patented drug of Eli Lilly and Company and sold under brand name Alimta. In 2004, Alimta (Pemetrexed injection) was approved by US FDA... View more

Coherent Market Insights Hemophilia Gene Therapy Market

Published Date : 13 Feb, 2026

Hemophilia is a genetic bleeding disorder in which an individual lacks or has low levels of proteins called clotting factors. There are around 13 types of clotting factors that work with blood platelets, which are necessary for clotting process to initiate. There are ... View more

Coherent Market Insights Short Bowel Syndrome Market

Published Date : 12 Feb, 2026

Short Bowel Syndrome Market Size and Forecast – 2026 – 2033 The global Short Bowel Syndrome market is projected to grow from around USD 2.5 billion in 2026 to about USD 7.9 billion by 2033, expanding at a 19.3% CAGR. This reflects strong growth driven by rising gastrointestinal disorders and ad... View more

Coherent Market Insights Pain Management Drugs Market

Published Date : 12 Feb, 2026

Pain management medications are specific drug classes, which have pharmacological actions on pain receptors and work against the pain symptoms. These medications include opioids, non-steroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, antidepressants, muscle ... View more

Coherent Market Insights Human Recombinant Insulin Market

Published Date : 12 Feb, 2026

Recombinant human insulin is the synthetic insulin, developed using recombinant DNA technology by growing insulin proteins within Escherichia coli. Recombinant human insulin has a faster onset of action and lower immunogenicity than other types of insulin such as pork... View more

Coherent Market Insights Metabolism Drugs Market

Published Date : 12 Feb, 2026

Metabolism functions improperly when enzymes and proteins are either not produced by the body (inherited disorders), or the produced enzymes do not function the way they are meant to. Metabolic disorders occur due to buildup of proteins, lipids, glycogen, urea, calciu... View more

Coherent Market Insights Europe Paclitaxel Market

Published Date : 12 Feb, 2026

According to Coherent Market Insights, the Europe paclitaxel market is estimated to be valued at USD 332.9 Mn in 2026 and is expected to reach USD 545.1 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of ... View more

Coherent Market Insights Antiplatelet Drugs Market

Published Date : 12 Feb, 2026

Antiplatelet drugs are prescribed to individuals with a history of heart attacks and these drugs aid in reducing reoccurrence of heart attacks. Some of the antiplatelet medications include, aspirin, clopidogrel, prasugrel, and ticagrelor. Aspirin is recommended for al... View more

Coherent Market Insights Pleurodynia Treatment Market

Published Date : 11 Feb, 2026

According to Coherent Market Insights, the global pleurodynia treatment market is estimated to be valued at USD 161.1 Mn in 2026 and is expected to reach USD 240.6 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of... View more

Coherent Market Insights Low Molecular Weight Heparin Market

Published Date : 11 Feb, 2026

Low Molecular Weight Heparins (LMWH) are a form of pharmacological anticoagulant intervention which are derived from unfractionated heparin (UFH) by chemical or enzymatic depolymerisation to yield fragments that are around one third the size of heparin.  Low mole... View more

Coherent Market Insights Lidocaine Patches Market

Published Date : 11 Feb, 2026

Lidocaine falls under the drug class of local anesthesia. Lidocaine patches are adhesive formulations that are used to help reduce itching and pain from certain skin conditions. Dermalid, Lidoderm, Ztildo are the prescription lidocaine transdermal patches used to reli... View more

Coherent Market Insights Ovarian Cancer Drugs Market

Published Date : 10 Feb, 2026

Ovarian Cancer Drugs Market Size and Forecast – 2026 – 2033 The ovarian cancer drugs market is valued at about USD 4.83 billion in 2026 and is forecast to reach around USD 6.65 billion by 2033, growing at a CAGR of 4.1 % from 2026 to 2033 as targeted therapies like PARP inhibitors drive... View more

Coherent Market Insights Rheumatoid Arthritis Treatment Market

Published Date : 10 Feb, 2026

Rheumatoid Arthritis Treatment Market Size and Forecast – 2026 – 2033 The global Rheumatoid Arthritis Treatment Market is projected to grow from about USD 32.7 billion in 2026 to around USD 48.2 billion by 2033, expanding at a CAGR of 5.7 % over 2026–2033, driven by rising RA prev... View more



LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

Reliability and Reputation

860519526

Reliability and Reputation
ISO 9001:2015

9001:2015

ISO 27001:2022

27001:2022

Reliability and Reputation
Reliability and Reputation
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.